Overexpression of galectin-3 is associated with enhancing metastasis and poor prognosis in several types of cancers, including colon, thyroid, gastric, liver, pancreatic ductal adenocarcinoma, bladder, and breast cancer [43–46]. Here, LGALS3 is linked to cancer.